Cardiotoxicity in dual immune checkpoint inhibitors: a critical appraisal of signal interpretation and future directions. [PDF]
Eur Heart J Cardiovasc PharmacotherDong W, Song Q, Wang Q.
europepmc +1 more source
Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice. [PDF]
Support Care CancerDitta SA +7 more
europepmc +1 more source
Effectiveness of self-management interventions in managing cancer therapy-induced cardiotoxicity in cancer survivors: a systematic review protocol. [PDF]
Syst RevYang M +5 more
europepmc +1 more source
No evidence for cardiotoxicity of miltefosine
Anais Brasileiros de Dermatologia, 2022 openaire +4 more sources
Cardiotoxicity adverse outcome pathway network: towards mechanistic and quantitative modelling. [PDF]
Front ToxicolLadeira L +4 more
europepmc +1 more source
A multimodal approach to early detection of anthracycline-induced cardiotoxicity: complementary roles of left ventricular global longitudinal strain, left atrial reservoir strain, and high-sensitivity troponin I. [PDF]
J Cardiovasc ImagingKaya AF, Özbek M.
europepmc +1 more source
Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity. [PDF]
CardiooncologyFerri GM +6 more
europepmc +1 more source
Risk factors for trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients. [PDF]
Front OncolZhang H, Hu S, Kong N.
europepmc +1 more source
Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. [PDF]
Arterioscler Thromb Vasc BiolHammond ST +5 more
europepmc +1 more source
Bone Regeneration Drug BMP-7 Mitigates Ponatinib-Induced Cardiotoxicity via Inhibition of Pyroptosis and Modulation of TGF-β/SMAD Signaling Pathway. [PDF]
CellsRolando JM, Singla DK.
europepmc +1 more source